US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
CS263203B1
(en)
*
|
1986-07-22 |
1989-04-14 |
Sulc Jiri |
Soft intraocular lenses
|
US5032109A
(en)
*
|
1987-02-10 |
1991-07-16 |
Drug Delivery Systems Inc. |
Electrolytic transdermal delivery of polypeptides
|
US4878892A
(en)
*
|
1987-02-10 |
1989-11-07 |
Drug Delivery Systems Inc. |
Electrolytic transdermal delivery of polypeptides
|
US5110600A
(en)
*
|
1988-01-25 |
1992-05-05 |
The Regents Of The University Of California |
Method of treating viral infections with amino acid analogs
|
US5192316A
(en)
*
|
1988-02-16 |
1993-03-09 |
Allergan, Inc. |
Ocular device
|
US4990336A
(en)
*
|
1989-02-08 |
1991-02-05 |
Biosearch, Inc. |
Sustained release dosage form
|
US5760261A
(en)
*
|
1990-02-28 |
1998-06-02 |
Guttag; Alvin |
Higher fatty acid derivatives of salicylic acid and salts thereof
|
US5173302A
(en)
*
|
1990-09-28 |
1992-12-22 |
Medtronic, Inc. |
Hydrophilic pressure sensitive adhesive for topical administration of hydrophobic drugs
|
ES2149178T3
(es)
*
|
1991-08-16 |
2000-11-01 |
Miles A Galin |
Implante ocular para la camara anterior refractivo, recubierto con un medicamento.
|
AU3469893A
(en)
*
|
1992-01-15 |
1993-08-03 |
Allergan, Inc. |
Hydrogel compositions and structures made from same
|
US5596007A
(en)
*
|
1992-05-18 |
1997-01-21 |
Pharmaco Behavioral Associates, Inc. |
Therapeutic method to alleviate the craving associated with cessation of tobacco with cotinine
|
US5643928A
(en)
*
|
1992-10-21 |
1997-07-01 |
Pharmaco Behavioral Associates, Inc. |
Human body weight management
|
US5612357A
(en)
*
|
1992-05-18 |
1997-03-18 |
Pharmaco Behavioral Associates, Inc. |
Use of cotinine to assist in the cessation of tobacco smoking
|
US5869505A
(en)
*
|
1993-02-02 |
1999-02-09 |
Keenan; Robert M. |
Nicotine metabolites and nicotine dependence
|
US5922340A
(en)
*
|
1992-09-10 |
1999-07-13 |
Children's Medical Center Corporation |
High load formulations and methods for providing prolonged local anesthesia
|
US5700485A
(en)
*
|
1992-09-10 |
1997-12-23 |
Children's Medical Center Corporation |
Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
|
CA2144407C
(en)
*
|
1992-09-10 |
2000-05-30 |
Charles B. Berde |
Biodegradable polymer matrices for sustained delivery of local anesthetic agents
|
US6162456A
(en)
*
|
1992-09-24 |
2000-12-19 |
Ortho-Mcneil Pharmaceutical, Inc. |
Adhesive transdermal drug delivery matrix of a physical blend of hydrophilic and hydrophobic polymers
|
US5989586A
(en)
*
|
1992-10-05 |
1999-11-23 |
Cygnus, Inc. |
Two-phase matrix for sustained release drug delivery device
|
US5573774A
(en)
*
|
1993-02-02 |
1996-11-12 |
Keenan; Robert M. |
Nicotine metabolites, nicotine dependence and human body weight
|
DE4313928C2
(de)
*
|
1993-04-28 |
1996-09-19 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
|
US5505952A
(en)
*
|
1994-04-19 |
1996-04-09 |
United States Surgical Corporation |
Modified synthetic cross-linked amino acid polymers and medical devices formed therefrom
|
US5972326A
(en)
*
|
1995-04-18 |
1999-10-26 |
Galin; Miles A. |
Controlled release of pharmaceuticals in the anterior chamber of the eye
|
US5612027A
(en)
*
|
1995-04-18 |
1997-03-18 |
Galin; Miles A. |
Controlled release of miotic and mydriatic drugs in the anterior chamber
|
NZ311474A
(en)
*
|
1995-06-09 |
1997-09-22 |
Euro Celtique Sa |
Formulations for providing prolonged local anesthesia
|
AU6286796A
(en)
*
|
1995-07-12 |
1997-02-10 |
Corning Incorporated |
Novel photochromic organic materials
|
US5723131A
(en)
|
1995-12-28 |
1998-03-03 |
Johnson & Johnson Vision Products, Inc. |
Contact lens containing a leachable absorbed material
|
JPH11511763A
(ja)
|
1996-06-24 |
1999-10-12 |
ユーロ―セルティーク,エス.エイ. |
安全な局所麻酔の提供方法
|
US6046187A
(en)
|
1996-09-16 |
2000-04-04 |
Children's Medical Center Corporation |
Formulations and methods for providing prolonged local anesthesia
|
US6476103B1
(en)
*
|
1996-10-11 |
2002-11-05 |
Corning Incorporated |
Photochromic organic material, its manufacture and the photochromic articles containing it
|
AUPO379596A0
(en)
*
|
1996-11-22 |
1996-12-19 |
Soltec Research Pty Ltd |
Percutaneous delivery system
|
EP1009390A4
(de)
|
1997-07-02 |
2004-05-06 |
Euro Celtique Sa |
Verlängerte narkose in gelenken und körperzwischenräumen
|
US6197785B1
(en)
|
1997-09-03 |
2001-03-06 |
Guilford Pharmaceuticals Inc. |
Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
|
US6426415B1
(en)
|
1997-09-03 |
2002-07-30 |
Guilford Pharmaceuticals Inc. |
Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
|
US6291425B1
(en)
|
1999-09-01 |
2001-09-18 |
Guilford Pharmaceuticals Inc. |
Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
|
US6514983B1
(en)
|
1997-09-03 |
2003-02-04 |
Guilford Pharmaceuticals Inc. |
Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
|
US6346536B1
(en)
|
1997-09-03 |
2002-02-12 |
Guilford Pharmaceuticals Inc. |
Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
|
US6635642B1
(en)
|
1997-09-03 |
2003-10-21 |
Guilford Pharmaceuticals Inc. |
PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
|
US6395749B1
(en)
|
1998-05-15 |
2002-05-28 |
Guilford Pharmaceuticals Inc. |
Carboxamide compounds, methods, and compositions for inhibiting PARP activity
|
US6387902B1
(en)
|
1998-12-31 |
2002-05-14 |
Guilford Pharmaceuticals, Inc. |
Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
|
US6410045B1
(en)
|
1999-02-22 |
2002-06-25 |
Clyde Lewis Schultz |
Drug delivery system for antiglaucomatous medication
|
US20020197300A1
(en)
*
|
1999-02-22 |
2002-12-26 |
Schultz Clyde L. |
Drug delivery system for anti-glaucomatous medication
|
TWI279401B
(en)
*
|
1999-08-31 |
2007-04-21 |
Incyte San Diego Inc |
Heterocyclic derivatives for the treatment of diabetes and other diseases
|
US6315987B1
(en)
*
|
2000-05-10 |
2001-11-13 |
Isp Investments Inc. |
Polymeric delivery and release systems for oral care actives
|
US6723733B2
(en)
|
2000-05-19 |
2004-04-20 |
Guilford Pharmaceuticals, Inc. |
Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses
|
US6348475B1
(en)
|
2000-06-01 |
2002-02-19 |
Guilford Pharmaceuticals Inc. |
Methods, compounds and compositions for treating gout
|
US20040151755A1
(en)
*
|
2000-12-21 |
2004-08-05 |
Osman Rathore |
Antimicrobial lenses displaying extended efficacy, processes to prepare them and methods of their use
|
EA200300982A1
(ru)
|
2001-03-07 |
2004-12-30 |
Инсайт Сан Диего, Инк. |
Гетероциклические производные для лечения рака и других пролиферативных заболеваний
|
CA2473156A1
(en)
*
|
2001-03-08 |
2002-09-19 |
Incyte San Diego, Inc. |
Rxr activating molecules
|
CA2340824A1
(en)
*
|
2001-03-14 |
2002-09-14 |
Ibm Canada Limited-Ibm Canada Limitee |
Method and system for application behavior analysis
|
US20030083357A1
(en)
*
|
2001-08-17 |
2003-05-01 |
Magnus Pfahl |
Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
|
EP1446099B1
(de)
*
|
2001-11-14 |
2009-07-15 |
Durect Corporation |
Injizierbare depotzusammensetzungen
|
KR20040058101A
(ko)
|
2001-11-14 |
2004-07-03 |
알자 코포레이션 |
카테터 주입가능한 데포 조성물 및 그의 용도
|
AU2002352706A1
(en)
|
2001-11-15 |
2003-06-10 |
Maxia Pharmaceuticals, Inc. |
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
|
US7102000B2
(en)
*
|
2002-03-08 |
2006-09-05 |
Incyte San Diego Inc. |
Heterocyclic amide derivatives for the treatment of diabetes and other diseases
|
US7196108B2
(en)
*
|
2002-03-08 |
2007-03-27 |
Incyte San Diego Inc. |
Bicyclic heterocycles for the treatment of diabetes and other diseases
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
WO2004011054A2
(en)
|
2002-07-31 |
2004-02-05 |
Alza Corporation |
Injectable multimodal polymer depot compositions and uses thereof
|
DE60226282T2
(de)
|
2002-07-31 |
2009-09-17 |
Alza Corp., Mountain View |
Injizierbare depotzusammensetzungen und deren verwendung
|
US7795203B2
(en)
*
|
2002-09-30 |
2010-09-14 |
Babizhayev Mark A |
Method for topical treatment of eye disease and composition and device for said treatment
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
WO2004066952A2
(en)
*
|
2003-01-29 |
2004-08-12 |
Incyte Corporation |
Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
|
KR20060036896A
(ko)
*
|
2003-04-18 |
2006-05-02 |
인사이트 산 디에고 인코포레이티드 |
대사 장애, 암 및 다른 질병의 치료를 위한 치환된이소크로만 화합물
|
WO2005007714A1
(ja)
*
|
2003-07-18 |
2005-01-27 |
Japan Exlan Company Limited |
アミノ酸誘導体徐放性重合体、該重合体を含有する化粧料及び繊維構造物並びにそれらの製造法及び再生処理法
|
PT1682537E
(pt)
|
2003-11-05 |
2012-06-20 |
Sarcode Bioscience Inc |
Moduladores de adesão celular
|
WO2006017275A1
(en)
|
2004-07-13 |
2006-02-16 |
The University Of Tennessee Research Foundation |
Adhesive composition for carrying therapeutic agents as delivery vehicle on coatings applied to vascular grafts
|
JP2008519847A
(ja)
*
|
2004-11-10 |
2008-06-12 |
ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク |
運動障害の治療方法
|
NZ554783A
(en)
*
|
2004-11-15 |
2010-12-24 |
Ceptyr Inc |
Protein tyrosine phosphatase inhibitors and methods of use thereof
|
US9804295B2
(en)
†
|
2005-05-05 |
2017-10-31 |
Novartis Ag |
Ophthalmic devices for sustained delivery of active compounds
|
LT2444079T
(lt)
|
2005-05-17 |
2017-03-27 |
Sarcode Bioscience Inc. |
Kompozicijos ir būdai, skirti akių sutrikimų gydymui
|
EP3081215B9
(de)
|
2005-05-23 |
2020-08-19 |
Natural Alternatives International, Inc. |
Zusammensetzungen und verfahren zur anhaltenden freisetzung von beta-alanin
|
DE102006052342B4
(de)
*
|
2006-11-07 |
2015-08-20 |
Wöhlk-Contact-Linsen GmbH |
Kontaktlinsenmaterial
|
US8071119B2
(en)
*
|
2007-05-14 |
2011-12-06 |
Sustained Nano Systems Llc |
Controlled release implantable dispensing device and method
|
US20090148498A1
(en)
*
|
2007-05-14 |
2009-06-11 |
Sustained Nano Systems Llc |
Controlled release implantable dispensing device and method
|
WO2008143906A2
(en)
*
|
2007-05-14 |
2008-11-27 |
Sustained Nano Systems Llc |
Hypercompressed particles for controlled release of ophthalmic medications
|
EA020466B1
(ru)
|
2007-06-04 |
2014-11-28 |
Синерджи Фармасьютикалз Инк. |
Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
MX2010004281A
(es)
|
2007-10-19 |
2010-09-10 |
Sarcode Corp |
Composiciones y metodos para el tratamiento de la retinopatia diabetica.
|
WO2009139817A2
(en)
|
2008-04-15 |
2009-11-19 |
Sarcode Corporation |
Crystalline pharmaceutical and methods of preparation and use thereof
|
EP2276508A4
(de)
*
|
2008-04-15 |
2011-12-28 |
Sarcode Bioscience Inc |
Freisetzung von lfa-1-antagonisten gegen das magen-darm-system
|
JP2011522828A
(ja)
|
2008-06-04 |
2011-08-04 |
シナジー ファーマシューティカルズ インコーポレイテッド |
胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
|
CA2730603C
(en)
|
2008-07-16 |
2019-09-24 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
US9732324B2
(en)
|
2008-10-23 |
2017-08-15 |
Cornell University |
Anti-viral method
|
US10201548B2
(en)
*
|
2009-03-06 |
2019-02-12 |
Sun Pharma Global Fze |
Methods for treating ocular inflammatory diseases
|
US10980818B2
(en)
|
2009-03-06 |
2021-04-20 |
Sun Pharma Global Fze |
Methods for treating ocular inflammatory diseases
|
US8299079B2
(en)
|
2009-05-22 |
2012-10-30 |
Kaufman Herbert E |
Preparations and methods for ameliorating or reducing presbyopia
|
US8378105B2
(en)
*
|
2009-10-21 |
2013-02-19 |
Sarcode Bioscience Inc. |
Crystalline pharmaceutical and methods of preparation and use thereof
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
CA2719512A1
(en)
|
2010-11-01 |
2012-05-01 |
Stiefel Research Australia Pty Ltd |
Polymeric topical compositions
|
MX362218B
(es)
|
2011-05-04 |
2019-01-09 |
Balance Therapeutics Inc |
Derivados de pentilentetrazol.
|
US20130004651A1
(en)
*
|
2011-07-01 |
2013-01-03 |
Patty Fu-Giles |
Sustained drug release from body implants using nanoparticle-embedded polymeric coating materials
|
EP3715345B1
(de)
|
2012-07-25 |
2024-04-10 |
Novartis AG |
Herstellung eines lfa-1-hemmers
|
EP2912121B1
(de)
|
2012-10-29 |
2019-09-25 |
Ariste Medical, LLC |
Polymerbeschichtungszusammensetzungen und beschichtete gegenstände
|
AU2014218599C1
(en)
|
2013-02-25 |
2018-09-06 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists for use in colonic cleansing
|
JP2016514670A
(ja)
|
2013-03-15 |
2016-05-23 |
シナジー ファーマシューティカルズ インコーポレイテッド |
他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
|
AU2014235215A1
(en)
|
2013-03-15 |
2015-10-01 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
CA2926691A1
(en)
|
2013-10-10 |
2015-04-16 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of opioid induced dysfunctions
|
EP3079668A1
(de)
|
2013-12-09 |
2016-10-19 |
Durect Corporation |
Pharmazeutisch aktive wirkstoffkomplexe, polymerkomplexe und zusammensetzungen und verfahren damit
|
AU2015249769A1
(en)
|
2014-04-22 |
2016-11-10 |
Ariste Medical, Llc. |
Methods and processes for application of drug delivery polymeric coatings
|
EP3291886A1
(de)
|
2015-05-04 |
2018-03-14 |
Ecole Polytechnique Federale de Lausanne (EPFL) |
Ophthalmische kontaktlinse mit komprimierbarer affinitätsmatrix
|
CN108884130B
(zh)
|
2016-01-11 |
2022-09-13 |
博士医疗爱尔兰有限公司 |
用于治疗溃疡性结肠炎的制剂和方法
|
PT109154B
(pt)
|
2016-02-12 |
2019-11-05 |
Univ De Coimbra |
Tecnologia não-invasiva de inserto ocular para libertação controlada de fármacos
|
KR20220140711A
(ko)
|
2020-01-13 |
2022-10-18 |
듀렉트 코퍼레이션 |
불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
|